| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphoma, Large B-Cell, Diffuse | 15 | 2010 | 1664 | 0.790 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2013 | 171 | 0.740 |
Why?
|
| Lymphoma, B-Cell | 12 | 2010 | 895 | 0.680 |
Why?
|
| Gene Expression Profiling | 17 | 2014 | 5159 | 0.620 |
Why?
|
| NF-kappa B | 13 | 2014 | 1549 | 0.570 |
Why?
|
| Drug Resistance, Neoplasm | 9 | 2015 | 5178 | 0.520 |
Why?
|
| Arthralgia | 1 | 2015 | 89 | 0.500 |
Why?
|
| Femur | 1 | 2015 | 158 | 0.500 |
Why?
|
| Bone Transplantation | 1 | 2015 | 134 | 0.500 |
Why?
|
| Hip Fractures | 1 | 2015 | 76 | 0.490 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 15 | 2013 | 2508 | 0.460 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2013 | 119 | 0.440 |
Why?
|
| B-Lymphocytes | 7 | 2010 | 1294 | 0.430 |
Why?
|
| Caspases | 4 | 2013 | 661 | 0.420 |
Why?
|
| Down-Regulation | 7 | 2013 | 2074 | 0.400 |
Why?
|
| Protein Kinases | 2 | 2013 | 874 | 0.390 |
Why?
|
| I-kappa B Proteins | 2 | 2013 | 170 | 0.390 |
Why?
|
| Guanidines | 1 | 2010 | 60 | 0.380 |
Why?
|
| Signal Transduction | 13 | 2014 | 11965 | 0.380 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2014 | 8873 | 0.370 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 589 | 0.360 |
Why?
|
| Pain, Postoperative | 1 | 2015 | 610 | 0.360 |
Why?
|
| Phenols | 1 | 2010 | 107 | 0.360 |
Why?
|
| Neoplasm Proteins | 8 | 2008 | 3230 | 0.340 |
Why?
|
| Lymphoma, Non-Hodgkin | 6 | 2014 | 1039 | 0.340 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2009 | 566 | 0.330 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2013 | 713 | 0.290 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 59 | 0.290 |
Why?
|
| Gene Expression Regulation, Leukemic | 6 | 2014 | 560 | 0.290 |
Why?
|
| RNA | 3 | 2010 | 1013 | 0.280 |
Why?
|
| Biological Assay | 1 | 2007 | 177 | 0.270 |
Why?
|
| Luciferases | 1 | 2007 | 445 | 0.270 |
Why?
|
| Multiple Myeloma | 7 | 2012 | 2138 | 0.270 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2014 | 1242 | 0.260 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2013 | 2390 | 0.260 |
Why?
|
| Lymphoma, Follicular | 3 | 2014 | 587 | 0.250 |
Why?
|
| I-kappa B Kinase | 7 | 2009 | 250 | 0.240 |
Why?
|
| Biomarkers, Tumor | 5 | 2013 | 10331 | 0.230 |
Why?
|
| Guanylate Cyclase | 5 | 2010 | 74 | 0.230 |
Why?
|
| Neoplastic Stem Cells | 2 | 2011 | 1443 | 0.220 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2013 | 3639 | 0.220 |
Why?
|
| CARD Signaling Adaptor Proteins | 5 | 2010 | 113 | 0.220 |
Why?
|
| Cell Survival | 7 | 2013 | 3045 | 0.210 |
Why?
|
| Tumor Cells, Cultured | 11 | 2015 | 5395 | 0.200 |
Why?
|
| Cell Line, Tumor | 17 | 2014 | 14551 | 0.200 |
Why?
|
| Boronic Acids | 2 | 2013 | 362 | 0.190 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2013 | 136 | 0.190 |
Why?
|
| Brain | 4 | 2010 | 4113 | 0.180 |
Why?
|
| Pyrazines | 2 | 2013 | 495 | 0.180 |
Why?
|
| Apoptosis | 11 | 2013 | 7591 | 0.180 |
Why?
|
| Humans | 75 | 2015 | 261506 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2013 | 1493 | 0.180 |
Why?
|
| Staining and Labeling | 2 | 1998 | 429 | 0.170 |
Why?
|
| Thalidomide | 2 | 2014 | 569 | 0.170 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 11 | 2015 | 15862 | 0.170 |
Why?
|
| Antineoplastic Agents | 10 | 2015 | 14289 | 0.170 |
Why?
|
| Blotting, Western | 7 | 2013 | 3536 | 0.170 |
Why?
|
| NAD | 1 | 1998 | 89 | 0.160 |
Why?
|
| RNA Interference | 5 | 2012 | 1408 | 0.160 |
Why?
|
| Hodgkin Disease | 3 | 2012 | 1429 | 0.160 |
Why?
|
| Parkinson Disease | 1 | 2005 | 708 | 0.160 |
Why?
|
| Gene Expression | 6 | 2014 | 3570 | 0.160 |
Why?
|
| Strontium Radioisotopes | 1 | 1997 | 26 | 0.150 |
Why?
|
| Lymphoma | 4 | 2002 | 1467 | 0.150 |
Why?
|
| Mediastinal Neoplasms | 3 | 2010 | 423 | 0.150 |
Why?
|
| Megakaryocytes | 1 | 1997 | 104 | 0.150 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1998 | 324 | 0.150 |
Why?
|
| Hematopoiesis | 2 | 2014 | 560 | 0.150 |
Why?
|
| Immunophenotyping | 5 | 2014 | 1681 | 0.140 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 1910 | 0.140 |
Why?
|
| DNA, Complementary | 5 | 2004 | 869 | 0.140 |
Why?
|
| Antigens, Bacterial | 2 | 2003 | 354 | 0.140 |
Why?
|
| HL-60 Cells | 2 | 2013 | 302 | 0.140 |
Why?
|
| Ohio | 1 | 2015 | 113 | 0.130 |
Why?
|
| Transcription, Genetic | 6 | 2010 | 3154 | 0.130 |
Why?
|
| Suction | 1 | 2015 | 104 | 0.130 |
Why?
|
| Membrane Glycoproteins | 3 | 2012 | 1073 | 0.130 |
Why?
|
| Therapeutic Irrigation | 1 | 2015 | 90 | 0.130 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2015 | 6915 | 0.120 |
Why?
|
| Peptides, Cyclic | 1 | 2015 | 139 | 0.120 |
Why?
|
| Osteotomy | 1 | 2015 | 100 | 0.120 |
Why?
|
| Bortezomib | 2 | 2013 | 543 | 0.120 |
Why?
|
| Receptors, OX40 | 1 | 2014 | 50 | 0.120 |
Why?
|
| Integrin alpha4beta1 | 1 | 2014 | 45 | 0.120 |
Why?
|
| Gene Library | 2 | 2006 | 294 | 0.120 |
Why?
|
| Bone Marrow | 5 | 2014 | 2358 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2014 | 864 | 0.120 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 121 | 0.120 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2013 | 17 | 0.120 |
Why?
|
| Leupeptins | 1 | 2013 | 68 | 0.120 |
Why?
|
| Acrylates | 1 | 2013 | 30 | 0.110 |
Why?
|
| Flow Cytometry | 7 | 2014 | 3033 | 0.110 |
Why?
|
| Receptor Cross-Talk | 1 | 2013 | 79 | 0.110 |
Why?
|
| Toll-Like Receptors | 1 | 2014 | 174 | 0.110 |
Why?
|
| Erythema Multiforme | 1 | 1992 | 14 | 0.110 |
Why?
|
| Fluorouracil | 1 | 1997 | 1944 | 0.110 |
Why?
|
| DNA-Binding Proteins | 4 | 2014 | 4821 | 0.110 |
Why?
|
| CD18 Antigens | 1 | 2012 | 83 | 0.110 |
Why?
|
| Blood Platelets | 1 | 1997 | 731 | 0.110 |
Why?
|
| Bacterial Proteins | 2 | 2003 | 1029 | 0.110 |
Why?
|
| Cell Proliferation | 8 | 2012 | 7226 | 0.110 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2013 | 212 | 0.110 |
Why?
|
| P-Selectin | 1 | 2012 | 124 | 0.110 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 221 | 0.100 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2013 | 248 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 1997 | 846 | 0.100 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2003 | 109 | 0.100 |
Why?
|
| Karyopherins | 1 | 2013 | 136 | 0.100 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2013 | 275 | 0.100 |
Why?
|
| Fibroma | 2 | 1991 | 85 | 0.100 |
Why?
|
| Equipment Design | 1 | 2015 | 1204 | 0.100 |
Why?
|
| Dog Diseases | 1 | 2012 | 73 | 0.100 |
Why?
|
| Intestinal Diseases | 1 | 1992 | 121 | 0.100 |
Why?
|
| Oncogene Protein v-maf | 1 | 2010 | 1 | 0.100 |
Why?
|
| Tumor Escape | 1 | 2013 | 251 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2010 | 1756 | 0.100 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2010 | 6 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2014 | 492 | 0.100 |
Why?
|
| Oligopeptides | 1 | 2013 | 429 | 0.100 |
Why?
|
| Lymphatic Diseases | 1 | 1991 | 128 | 0.100 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 347 | 0.090 |
Why?
|
| CD79 Antigens | 1 | 2010 | 7 | 0.090 |
Why?
|
| T-Lymphocytes | 3 | 2012 | 3869 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2008 | 621 | 0.090 |
Why?
|
| Plasma Cells | 1 | 2010 | 192 | 0.090 |
Why?
|
| Antibodies | 2 | 1992 | 838 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 673 | 0.090 |
Why?
|
| Cryptocarya | 1 | 2009 | 1 | 0.090 |
Why?
|
| RNA, Neoplasm | 2 | 2010 | 771 | 0.090 |
Why?
|
| Gadolinium | 1 | 2010 | 164 | 0.090 |
Why?
|
| Pyrones | 1 | 2009 | 10 | 0.090 |
Why?
|
| Adoptive Transfer | 1 | 2012 | 446 | 0.090 |
Why?
|
| Casein Kinases | 1 | 2008 | 7 | 0.090 |
Why?
|
| Skin Diseases | 1 | 1992 | 349 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2010 | 392 | 0.090 |
Why?
|
| Immunosuppressive Agents | 2 | 2014 | 1375 | 0.090 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 442 | 0.090 |
Why?
|
| Plants, Medicinal | 1 | 2009 | 44 | 0.090 |
Why?
|
| Cyclosporins | 2 | 1999 | 112 | 0.090 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 392 | 0.080 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2010 | 113 | 0.080 |
Why?
|
| Comorbidity | 1 | 2015 | 2352 | 0.080 |
Why?
|
| Lactones | 1 | 2009 | 94 | 0.080 |
Why?
|
| Up-Regulation | 6 | 2005 | 2450 | 0.080 |
Why?
|
| Annexin A5 | 2 | 1999 | 72 | 0.080 |
Why?
|
| Receptors, Antigen | 1 | 2008 | 76 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 591 | 0.080 |
Why?
|
| Triazoles | 1 | 2013 | 617 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2010 | 397 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 371 | 0.080 |
Why?
|
| Helicobacter Infections | 2 | 2003 | 1216 | 0.080 |
Why?
|
| Genes, p53 | 1 | 2003 | 1090 | 0.080 |
Why?
|
| CD40 Antigens | 2 | 2007 | 104 | 0.080 |
Why?
|
| Skin Neoplasms | 2 | 2003 | 4654 | 0.080 |
Why?
|
| Sirolimus | 1 | 2012 | 814 | 0.080 |
Why?
|
| Middle Aged | 17 | 2015 | 86204 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2003 | 5437 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 492 | 0.070 |
Why?
|
| src-Family Kinases | 1 | 2010 | 478 | 0.070 |
Why?
|
| Adenocarcinoma | 3 | 2012 | 7789 | 0.070 |
Why?
|
| Acute Disease | 3 | 1998 | 2422 | 0.070 |
Why?
|
| beta Catenin | 1 | 2010 | 688 | 0.070 |
Why?
|
| Imidazoles | 1 | 2012 | 999 | 0.070 |
Why?
|
| Adult | 19 | 2015 | 77950 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2009 | 1385 | 0.070 |
Why?
|
| Actins | 1 | 2009 | 608 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2014 | 4078 | 0.070 |
Why?
|
| RNA, Messenger | 8 | 2014 | 6150 | 0.070 |
Why?
|
| Genetic Markers | 3 | 2004 | 974 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2010 | 850 | 0.070 |
Why?
|
| Jurkat Cells | 4 | 2008 | 311 | 0.070 |
Why?
|
| Macrophages | 1 | 2012 | 1304 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2012 | 5270 | 0.070 |
Why?
|
| Computational Biology | 2 | 2003 | 1271 | 0.070 |
Why?
|
| Putamen | 1 | 2005 | 26 | 0.070 |
Why?
|
| Substantia Nigra | 1 | 2005 | 41 | 0.070 |
Why?
|
| Thymus Neoplasms | 1 | 1990 | 400 | 0.070 |
Why?
|
| Stomach Neoplasms | 2 | 2003 | 2278 | 0.070 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2005 | 33 | 0.070 |
Why?
|
| Tumor Microenvironment | 2 | 2013 | 2864 | 0.070 |
Why?
|
| Male | 21 | 2015 | 123000 | 0.070 |
Why?
|
| Lung | 2 | 2012 | 3151 | 0.070 |
Why?
|
| RGS Proteins | 1 | 2005 | 61 | 0.070 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 2 | 2006 | 301 | 0.070 |
Why?
|
| Melanocytes | 2 | 2003 | 219 | 0.070 |
Why?
|
| Leukemia, B-Cell | 1 | 2006 | 117 | 0.060 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1998 | 2979 | 0.060 |
Why?
|
| Immunoglobulin Variable Region | 2 | 2003 | 173 | 0.060 |
Why?
|
| Incidence | 1 | 2015 | 5673 | 0.060 |
Why?
|
| Mice, SCID | 3 | 2015 | 1869 | 0.060 |
Why?
|
| Prognosis | 7 | 2013 | 21713 | 0.060 |
Why?
|
| Mice | 10 | 2015 | 34495 | 0.060 |
Why?
|
| Oncogenes | 1 | 2008 | 673 | 0.060 |
Why?
|
| Drug Design | 2 | 2006 | 375 | 0.060 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2009 | 852 | 0.060 |
Why?
|
| Cells, Cultured | 5 | 2014 | 5637 | 0.060 |
Why?
|
| Quinolines | 1 | 2007 | 383 | 0.060 |
Why?
|
| Female | 19 | 2015 | 141928 | 0.060 |
Why?
|
| U937 Cells | 2 | 2015 | 171 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 264 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 311 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2013 | 3552 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 1489 | 0.060 |
Why?
|
| Contrast Media | 1 | 2010 | 1472 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2015 | 9244 | 0.060 |
Why?
|
| Leukemia, Myeloid | 2 | 1999 | 941 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 2 | 2012 | 1165 | 0.060 |
Why?
|
| Pharmacokinetics | 1 | 2003 | 42 | 0.060 |
Why?
|
| Vincristine | 5 | 2012 | 1511 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 1399 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1037 | 0.060 |
Why?
|
| Cyclophosphamide | 5 | 2014 | 3001 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2008 | 1538 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2015 | 32848 | 0.060 |
Why?
|
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 3 | 2008 | 24 | 0.060 |
Why?
|
| Animals | 12 | 2015 | 59536 | 0.060 |
Why?
|
| Cluster Analysis | 1 | 2005 | 1053 | 0.050 |
Why?
|
| Autoantibodies | 2 | 2003 | 576 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2003 | 542 | 0.050 |
Why?
|
| Aged | 14 | 2014 | 70117 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2008 | 1152 | 0.050 |
Why?
|
| Cell Line | 4 | 2009 | 5114 | 0.050 |
Why?
|
| Skin | 2 | 2002 | 1259 | 0.050 |
Why?
|
| Supratentorial Neoplasms | 1 | 2002 | 78 | 0.050 |
Why?
|
| Phosphorylation | 4 | 2012 | 4804 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2003 | 247 | 0.050 |
Why?
|
| Nuclear Proteins | 4 | 2005 | 3343 | 0.050 |
Why?
|
| Repressor Proteins | 2 | 2010 | 1664 | 0.050 |
Why?
|
| Prednisone | 4 | 2012 | 984 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 3 | 2014 | 1581 | 0.050 |
Why?
|
| Doxorubicin | 4 | 2014 | 3005 | 0.050 |
Why?
|
| Cell Separation | 2 | 2014 | 612 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2015 | 37905 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 862 | 0.050 |
Why?
|
| Graft vs Host Disease | 1 | 1992 | 2638 | 0.050 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2004 | 388 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 1064 | 0.050 |
Why?
|
| RNA Stability | 1 | 2001 | 125 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 803 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 2359 | 0.050 |
Why?
|
| Biopsy | 3 | 2010 | 3443 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 1121 | 0.050 |
Why?
|
| Mutation | 5 | 2010 | 15179 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2001 | 266 | 0.050 |
Why?
|
| Ultraviolet Rays | 2 | 2004 | 575 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2004 | 268 | 0.050 |
Why?
|
| Flavonoids | 1 | 2001 | 188 | 0.050 |
Why?
|
| Aged, 80 and over | 7 | 2014 | 29902 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 2010 | 4849 | 0.050 |
Why?
|
| Interferon-alpha | 1 | 2004 | 889 | 0.050 |
Why?
|
| Ependymoma | 1 | 2002 | 242 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2013 | 2216 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2004 | 351 | 0.050 |
Why?
|
| RNA Editing | 1 | 2000 | 92 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2002 | 321 | 0.050 |
Why?
|
| Cell Cycle | 3 | 2012 | 2084 | 0.050 |
Why?
|
| Colon | 1 | 2004 | 670 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2004 | 755 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2005 | 992 | 0.040 |
Why?
|
| Pyrogallol | 1 | 1998 | 1 | 0.040 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 1998 | 13 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 1999 | 875 | 0.040 |
Why?
|
| Vidarabine | 1 | 2004 | 1341 | 0.040 |
Why?
|
| Genes, MDR | 1 | 1999 | 38 | 0.040 |
Why?
|
| Organotechnetium Compounds | 1 | 1999 | 44 | 0.040 |
Why?
|
| Nitroprusside | 1 | 1998 | 48 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 1217 | 0.040 |
Why?
|
| Drug Synergism | 2 | 2012 | 1313 | 0.040 |
Why?
|
| Bromodeoxyuridine | 1 | 1998 | 139 | 0.040 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 1999 | 749 | 0.040 |
Why?
|
| Interleukin-10 | 2 | 2014 | 478 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2007 | 1823 | 0.040 |
Why?
|
| Helicobacter pylori | 2 | 2003 | 1295 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 1999 | 204 | 0.040 |
Why?
|
| B-Cell CLL-Lymphoma 10 Protein | 2 | 2008 | 30 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2007 | 4367 | 0.040 |
Why?
|
| Remission Induction | 4 | 2014 | 3569 | 0.040 |
Why?
|
| Immunohistochemistry | 5 | 2013 | 7548 | 0.040 |
Why?
|
| Medulloblastoma | 1 | 2002 | 540 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 6089 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 10035 | 0.040 |
Why?
|
| Scapula | 1 | 1996 | 37 | 0.030 |
Why?
|
| Epitopes | 2 | 2003 | 685 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2008 | 4757 | 0.030 |
Why?
|
| Piperidines | 1 | 2001 | 1035 | 0.030 |
Why?
|
| Rituximab | 2 | 2014 | 1528 | 0.030 |
Why?
|
| fas Receptor | 3 | 2004 | 185 | 0.030 |
Why?
|
| Granuloma, Plasma Cell | 1 | 1995 | 38 | 0.030 |
Why?
|
| Rats | 3 | 1999 | 6086 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2015 | 3821 | 0.030 |
Why?
|
| Genomics | 1 | 2006 | 2738 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2008 | 4233 | 0.030 |
Why?
|
| Adolescent | 7 | 2010 | 31252 | 0.030 |
Why?
|
| Neprilysin | 1 | 1994 | 66 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2008 | 1823 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 1998 | 750 | 0.030 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 1997 | 285 | 0.030 |
Why?
|
| Herpesviridae Infections | 1 | 1995 | 175 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 7702 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 6942 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2014 | 206 | 0.030 |
Why?
|
| Chemokine CCL22 | 1 | 2013 | 13 | 0.030 |
Why?
|
| Chemokine CCL17 | 1 | 2013 | 14 | 0.030 |
Why?
|
| Graft Rejection | 1 | 1998 | 834 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 394 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 1994 | 4744 | 0.030 |
Why?
|
| Caco-2 Cells | 2 | 2004 | 158 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2015 | 269 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2005 | 185 | 0.030 |
Why?
|
| Plasmids | 2 | 2007 | 837 | 0.030 |
Why?
|
| Benzamides | 1 | 1998 | 1832 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 218 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 1997 | 943 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 1487 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1992 | 43 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 905 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 626 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2014 | 10001 | 0.030 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2012 | 61 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2012 | 55 | 0.030 |
Why?
|
| Likelihood Functions | 2 | 2003 | 233 | 0.030 |
Why?
|
| Glioma | 1 | 2003 | 1963 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 1992 | 226 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2012 | 67 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 600 | 0.030 |
Why?
|
| Child | 6 | 2010 | 29154 | 0.030 |
Why?
|
| Etoposide | 3 | 1999 | 870 | 0.030 |
Why?
|
| Base Sequence | 3 | 2004 | 4917 | 0.030 |
Why?
|
| Liver | 2 | 1999 | 2961 | 0.030 |
Why?
|
| Mesenteric Lymphadenitis | 1 | 1991 | 1 | 0.030 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 1991 | 47 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2002 | 1797 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 995 | 0.030 |
Why?
|
| Histological Techniques | 1 | 1991 | 65 | 0.020 |
Why?
|
| Wnt3 Protein | 1 | 2010 | 17 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 503 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2014 | 1008 | 0.020 |
Why?
|
| Casein Kinase Ialpha | 1 | 2010 | 16 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 591 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 1995 | 966 | 0.020 |
Why?
|
| Wnt3A Protein | 1 | 2010 | 29 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2012 | 214 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 1996 | 631 | 0.020 |
Why?
|
| Fever of Unknown Origin | 1 | 1991 | 63 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2008 | 1439 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2012 | 335 | 0.020 |
Why?
|
| Transfection | 2 | 2007 | 2944 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 528 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 622 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 163 | 0.020 |
Why?
|
| Histiocytosis, Sinus | 1 | 1991 | 86 | 0.020 |
Why?
|
| Chemokines | 1 | 2012 | 314 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2014 | 619 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2010 | 220 | 0.020 |
Why?
|
| Cell Division | 2 | 2004 | 2489 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 1994 | 1363 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 161 | 0.020 |
Why?
|
| Prednisolone | 2 | 2003 | 123 | 0.020 |
Why?
|
| Dogs | 1 | 2012 | 1155 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1077 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2014 | 825 | 0.020 |
Why?
|
| Tetraspanin 28 | 1 | 2009 | 13 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 1082 | 0.020 |
Why?
|
| Leukemia | 2 | 1999 | 1635 | 0.020 |
Why?
|
| Syk Kinase | 1 | 2009 | 56 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2007 | 14889 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2010 | 290 | 0.020 |
Why?
|
| Everolimus | 1 | 2012 | 415 | 0.020 |
Why?
|
| Plant Stems | 1 | 2009 | 8 | 0.020 |
Why?
|
| Malaysia | 1 | 2009 | 20 | 0.020 |
Why?
|
| Melphalan | 1 | 2012 | 834 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 11538 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 630 | 0.020 |
Why?
|
| Combined Modality Therapy | 3 | 2012 | 8865 | 0.020 |
Why?
|
| Homeostasis | 1 | 2014 | 950 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2009 | 61 | 0.020 |
Why?
|
| Time Factors | 2 | 2005 | 12926 | 0.020 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2012 | 588 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 413 | 0.020 |
Why?
|
| Genotype | 2 | 2001 | 4109 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2005 | 1442 | 0.020 |
Why?
|
| Spleen | 1 | 1991 | 676 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 1519 | 0.020 |
Why?
|
| Mitoxantrone | 2 | 1999 | 216 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2007 | 1879 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2010 | 576 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 3472 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 193 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2009 | 267 | 0.020 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2007 | 37 | 0.020 |
Why?
|
| Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2007 | 18 | 0.020 |
Why?
|
| Tyrosine | 1 | 2009 | 498 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2012 | 612 | 0.020 |
Why?
|
| Intestines | 1 | 1992 | 686 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2009 | 515 | 0.020 |
Why?
|
| Deubiquitinating Enzyme CYLD | 1 | 2007 | 23 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2007 | 84 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 1048 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2007 | 22 | 0.020 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2007 | 26 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 703 | 0.020 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2007 | 54 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 1996 | 1350 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2010 | 461 | 0.020 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2014 | 1048 | 0.020 |
Why?
|
| Phenotype | 2 | 2014 | 6295 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 4143 | 0.020 |
Why?
|
| Disease Progression | 1 | 1998 | 6682 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 734 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2007 | 125 | 0.020 |
Why?
|
| Melanoma | 1 | 2004 | 5317 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2010 | 561 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2007 | 202 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 354 | 0.020 |
Why?
|
| Janus Kinases | 1 | 2007 | 174 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2010 | 679 | 0.020 |
Why?
|
| Indoles | 1 | 2012 | 1009 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 810 | 0.020 |
Why?
|
| Genome, Human | 2 | 2008 | 1869 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2008 | 652 | 0.020 |
Why?
|
| Fibroblasts | 2 | 2003 | 1682 | 0.020 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2005 | 20 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 931 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 1533 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2005 | 47 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 1546 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2006 | 549 | 0.020 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2004 | 55 | 0.020 |
Why?
|
| Carbolines | 1 | 2005 | 27 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2012 | 1818 | 0.020 |
Why?
|
| Glycolysis | 1 | 2007 | 519 | 0.020 |
Why?
|
| Survival Rate | 2 | 2012 | 12221 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 5710 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 80 | 0.020 |
Why?
|
| Opossums | 1 | 2004 | 23 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 669 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2005 | 289 | 0.020 |
Why?
|
| Mesalamine | 1 | 2004 | 9 | 0.020 |
Why?
|
| Azathioprine | 1 | 2004 | 66 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2005 | 331 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 205 | 0.010 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2005 | 146 | 0.010 |
Why?
|
| Lomustine | 1 | 2003 | 39 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 1999 | 2314 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2007 | 1764 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2005 | 299 | 0.010 |
Why?
|
| Young Adult | 2 | 2014 | 21445 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1996 | 2576 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 101 | 0.010 |
Why?
|
| Radiation, Ionizing | 1 | 2004 | 187 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2003 | 33 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 1265 | 0.010 |
Why?
|
| Histones | 1 | 2010 | 1466 | 0.010 |
Why?
|
| Gastrointestinal Agents | 1 | 2004 | 108 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6207 | 0.010 |
Why?
|
| Keratins | 1 | 2004 | 330 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2007 | 1038 | 0.010 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2003 | 102 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 13658 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2003 | 141 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2003 | 383 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2003 | 141 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2002 | 191 | 0.010 |
Why?
|
| Cytokines | 1 | 2012 | 2809 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 777 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2003 | 218 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2330 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 304 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2007 | 854 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 3438 | 0.010 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 2001 | 12 | 0.010 |
Why?
|
| Trisomy | 1 | 2003 | 231 | 0.010 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2001 | 43 | 0.010 |
Why?
|
| Infant | 2 | 2010 | 13310 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 1213 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2005 | 709 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2007 | 1245 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2001 | 145 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 1399 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2005 | 783 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2002 | 241 | 0.010 |
Why?
|
| Cytarabine | 2 | 1999 | 1973 | 0.010 |
Why?
|
| Cytogenetic Analysis | 1 | 2003 | 568 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 3203 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 1960 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2003 | 402 | 0.010 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2004 | 430 | 0.010 |
Why?
|
| Immunoglobulin J-Chains | 1 | 2000 | 8 | 0.010 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 1 | 2000 | 6 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 1070 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2010 | 16273 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2003 | 351 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2005 | 876 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2000 | 73 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2014 | 3341 | 0.010 |
Why?
|
| Agammaglobulinemia | 1 | 2000 | 46 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 1618 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1991 | 2967 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2003 | 8223 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2008 | 2483 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2003 | 6869 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2003 | 641 | 0.010 |
Why?
|
| Neoplasms | 1 | 2006 | 15193 | 0.010 |
Why?
|
| X Chromosome | 1 | 2000 | 339 | 0.010 |
Why?
|
| Hepatitis, Animal | 1 | 1999 | 5 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 4053 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1999 | 52 | 0.010 |
Why?
|
| Autoradiography | 1 | 1999 | 132 | 0.010 |
Why?
|
| Filgrastim | 1 | 1999 | 191 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2000 | 512 | 0.010 |
Why?
|
| Biomarkers | 2 | 2002 | 5047 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1999 | 184 | 0.010 |
Why?
|
| Technetium | 1 | 1998 | 77 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 2049 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2002 | 889 | 0.010 |
Why?
|
| Pyridines | 1 | 2005 | 1244 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1999 | 660 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1999 | 408 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 2086 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2003 | 686 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 4938 | 0.010 |
Why?
|
| Mercaptopurine | 1 | 1996 | 130 | 0.010 |
Why?
|
| Asparaginase | 1 | 1996 | 184 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1996 | 193 | 0.010 |
Why?
|
| Ifosfamide | 1 | 1996 | 344 | 0.010 |
Why?
|
| Daunorubicin | 1 | 1996 | 301 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2000 | 1143 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 3254 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 2063 | 0.010 |
Why?
|
| Kidney | 1 | 2003 | 2146 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1996 | 829 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2004 | 5112 | 0.010 |
Why?
|
| Proteins | 1 | 2002 | 1963 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 2927 | 0.010 |
Why?
|
| Methotrexate | 1 | 1996 | 999 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1995 | 671 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1998 | 2843 | 0.010 |
Why?
|
| Paraffin | 1 | 1991 | 13 | 0.010 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1996 | 482 | 0.010 |
Why?
|
| Palatine Tonsil | 1 | 1991 | 53 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1998 | 908 | 0.010 |
Why?
|
| Formaldehyde | 1 | 1991 | 114 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1991 | 195 | 0.010 |
Why?
|
| Algorithms | 1 | 2002 | 3890 | 0.010 |
Why?
|
| Splenectomy | 1 | 1991 | 158 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 1999 | 2054 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 1991 | 666 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 1991 | 231 | 0.010 |
Why?
|
| Cisplatin | 1 | 1996 | 2432 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1997 | 9180 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1999 | 2195 | 0.000 |
Why?
|
| Risk Factors | 1 | 2002 | 17523 | 0.000 |
Why?
|
| Antigens, Neoplasm | 1 | 1991 | 1506 | 0.000 |
Why?
|
| Recurrence | 1 | 1991 | 4758 | 0.000 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1996 | 2796 | 0.000 |
Why?
|